Skip to content
Recruiting

Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy

About this study

This randomized controlled clinical trial evaluates neurocognitive, biopsychological, and brain connectome outcomes in children and adolescents with acute lymphoblastic leukemia who have previously received Chimeric Antigen Receptor T-cell therapy (CAR T-cell therapy), chemotherapy, and/or hematopoietic stem cell transplantation (HSCT). Participants will receive a multimodal, telematic psychological intervention combining digital cognitive training and an adapted mindfulness-based emotional regulation program. Outcomes will be compared with a waitlist control group and intervention sequences will be counterbalanced: (1) cognitive training followed by mindfulness; and (2) mindfulness followed by cognitive training. Neurocognitive performance, emotional-behavioral functioning, executive functioning and EEG-based functional connectivity will be assessed at baseline, post-intervention and at 6 months follow-up.

Condition
Acute Lymphoblastic Leukemia
Tested
Digital cognitive training, Online Mindfulness-Based Intervention
Sponsor
Hospital Universitario La Paz

Who can join

Age
8 to 18 years
Sex
All sexes
Healthy volunteers
Not accepted

Inclusion 8

  • Minimum age: 8 years
  • Maximum age: 18 years
  • Study condition: Acute Lymphoblastic Leukemia
  • Diagnosis of acute B-cell lymphoblastic leukemia.
  • Previous treatment with CAR-T therapy, chemotherapy, and/or hematopoietic stem cell transplantation.
  • Age between 8 and 18 years.
  • Native Spanish speaker or high proficiency in Spanish sufficient to understand study procedures and complete assessment instruments.
  • Access to a computer, tablet, or smartphone with an Internet connection.

Exclusion 2

  • Diagnosis of intellectual disability, autism spectrum disorder, or acquired brain injury.
  • Presence of uncontrolled or unstable medical or psychiatric conditions unrelated to leukemia.

Where

1 site, 1 recruiting

Hospital Universitario La Paz

Madrid, Madrid, Spain

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.